本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CSL Ltd.

66.50
-0.5400-0.81%
成交量:9.01萬
成交額:602.57萬
市值:644.22億
市盈率:30.26
高:67.28
開:66.70
低:66.44
收:67.04
52周最高:101.44
52周最低:64.68
股本:9.69億
流通股本:9.63億
量比:0.49
換手率:0.01%
股息:1.41
股息率:2.12%
每股收益(TTM):2.20
每股收益(LYR):2.40
淨資產收益率:15.37%
總資產收益率:6.63%
市淨率:3.33
市盈率(LYR):27.65

資料載入中...

公司資料

公司名字:
CSL Ltd.
交易所:
OTCQX
成立時間:
1916
員工人數:
29904
公司地址:
655 Elizabeth Street,Melbourne,Victoria,Australia
郵編:
3000
傳真:
61 3 9389 1434
簡介:
CSL is a global specialty biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent serious and rare medical conditions. We produce safe and effective therapies for patients who rely on them for their quality of life, and sometimes for life itself. Innovation is at the heart of everything we do. It is reflected in our creation of state-of-the-art plasma collection and manufacturing facilities, our investment in improving current therapies, finding new indications for existing therapies, and innovating new therapeutic products for unmet needs